BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Deals

  Merck Cements Dedication to Cardiovascular Disease with $11.5 Acceleron Acquisition

  Merck will acquire Acceleron for the expected $180 per share in cash for an approximate total equity value of $11.5 billion.

  September 30, 2021

   · 

  3 min read

   · 

  Heather McKenzie
• 

  Drug Development

  Eli Lilly Doubles Down with Positive Results in T2D and Alopecia Trials

  Indianapolis-based Eli Lilly presented data from two tirzepatide sub-studies at the 57th European Association for the Study of Diabetes (EASD) Annual Meeting.

  September 30, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Policy

  More Details About COVID-19 Vaccine Booster Shots

  The Pfizer-BioNTech booster shot is now authorized for people over 18 and 65 who are immunocompromised, at high risk due to their work or living situation and front-line healthcare workers.

  September 30, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Otsuka and Sunovion Ink Neuropsychiatric Medicine Deal Worth Nearly $1 Billion

  The companies said the collaboration recognizes a “great need for novel treatments in the area of neuropsychiatric medicine development.”

  September 30, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Ferring Biotherapeutic Packs a Punch in C. Difficile Infection Across Five Trials

  Ferring Pharmaceuticals today announced positive results across all five of its prospective trials for a live biotherapeutic designed to reduce recurrent C. difficile infection (rCDI).

  September 30, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Business

  BioSpace Movers & Shakers, Oct. 1

  Biopharma companies and life sciences organizations strengthen their leadership teams and boards with these Movers & Shakers.

  September 30, 2021

   · 

  4 min read

   · 

  Alex Keown
• 

  Job Trends

  Philadelphia Bursting at the Seams as Biopharma Hub Status Grows

  As the city rapidly develops as a biopharma hub, wet lab space is rapidly dwindling.

  September 30, 2021

   · 

  4 min read

   · 

  Alex Keown
• 

  Biotech Beach

  Research Roundup: Epilepsy Drug Improves Cognition in Some Alzheimer’s Patients and More

  Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

  September 30, 2021

   · 

  5 min read

   · 

  Mark Terry
• 

  Drug Development

  Mirum Snags First Approval for LIVMARLI Drug for Treating Rare, Genetic Liver Disorder

  LIVMARLI is indicated for ages one year and older and will now be accessible to patients with a prescription through Mirum Access Plus. Here’s more about it.

  September 30, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Career Advice

  Want to Stay Ahead of The Curve? Here is What You Need to Do for Career Development

  Here are some effective career development tips that can help you stay ahead and accomplish milestones. Don;t miss any of it if you want a successful career.

  September 30, 2021

   · 

  2 min read

   · 

  Brandi Marcene